Skip to main content

Betamethasone Acetate/Betamethasone Sodium Phosphate Suspension for Injection Shortage

Last Updated: November 18, 2019
Status: Resolved

Reason for the Shortage
    • American Regent had betamethasone acetate/betamethasone sodium phosphate on shortage due to minor shipping delays.
    • Merck did not provide a reason for the shortage.
    • Exela Pharma Sciences had betamethasone acetate/betamethasone sodium phosphate on shortage due to increased demand.
Available Products
    • Celestone Soluspan suspension for injection, Merck, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00085-4320-01
    • Betamethasone acetate/betamethasone sodium phosphate suspension for injection, American Regent, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00517-0720-01
    • Betamethasone acetate/betamethasone sodium phosphate suspension for injection, Exela Pharma Sciences, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 51754-5060-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated November 18, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer